Unicycive Therapeutics
Signal active
Organization
Contact Information
Overview
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs. It aims to open the way for a broad range of disease-modifying therapies by modifying the intracellular and extracellular concentrations of these various electrolytes and ions in Chronic Kidney Disease and Gitelman’s Syndrome and by addressing the underlying mitochondrial pathology and inflammation associated with Acute Kidney Disease.
Unicycive Therapeutics was founded in 2016 and is headquartered in Los Altos, California.
About
Industries
Biotechnology, Health Care, Medical, Health Diagnostics
Founded
2016
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Unicycive Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $5.5B in funding across 64 round(s). With a team of 11-50 employees, Unicycive Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Unicycive Therapeutics, raised $50.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
8
Lead Investors
0
Total Funding Amount
$86.6M
Details
2
Unicycive Therapeutics has raised a total of $86.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 6.0M | ||
| 2020 | Seed | 604.1K |
Investors
Unicycive Therapeutics is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Unicycive Therapeutics | - | FUNDING ROUND - Unicycive Therapeutics | 50.0M |
| Velan Capital | - | FUNDING ROUND - Velan Capital | 50.0M |
| Unicycive Therapeutics | - | FUNDING ROUND - Unicycive Therapeutics | 50.0M |
| Great Point Partners | - | FUNDING ROUND - Great Point Partners | 50.0M |
Recent Activity
There is no recent news or activity for this profile.